149 related articles for article (PubMed ID: 34654763)
1. Evaluation of Possible Effects of the COVID-19 Pandemic on Febrile Neutropenia Episodes in Children With Acute Leukemia.
Erbaş İC; Tüfekçi Ö; Akyol Ş; Asrak HK; Güzin AÇ; Alataş ŞÖ; Yilmaz Ş; Ören H; Belet N
J Pediatr Hematol Oncol; 2022 Oct; 44(7):e976-e981. PubMed ID: 34654763
[TBL] [Abstract][Full Text] [Related]
2. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.
Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N
Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Febrile Neutropenia in Pediatric Patients With Cancer Before and After Implementation of Coronavirus Disease 2019 Precautions.
Kibby D; Trinkman H; Ray A; Hamby T; Orr K
J Pediatr Hematol Oncol; 2023 May; 45(4):e479-e482. PubMed ID: 36716242
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
[TBL] [Abstract][Full Text] [Related]
6. Impact of socio-behavioral measures implemented during the SARS-CoV-2 pandemic on the outcomes of febrile neutropenia episodes in pediatric cancer patients: a single center quasi-experimental pre-post study.
Nessle CN; Braun T; Chopra V; Choi SW; Mody R
Pediatr Hematol Oncol; 2023 May; 40(4):412-421. PubMed ID: 36125251
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.
Yoshino N; Kimura SI; Matsuoka A; Meno T; Ishikawa T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Misaki Y; Yoshimura K; Gomyo A; Okada Y; Tamaki M; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Wada H; Nakasone H; Kako S; Kanda Y
J Infect Chemother; 2023 Apr; 29(4):384-390. PubMed ID: 36669687
[TBL] [Abstract][Full Text] [Related]
8. c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.
Kubo H; Imataki O; Kubo YH; Uemura M
PLoS One; 2022; 17(3):e0263623. PubMed ID: 35298471
[TBL] [Abstract][Full Text] [Related]
9. c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.
Kubo H; Imataki O; Kubo YH; Uemura M; Kadowaki N
Int J Clin Oncol; 2019 May; 24(5):590-595. PubMed ID: 30604157
[TBL] [Abstract][Full Text] [Related]
10. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings.
Lappalainen M; Hämäläinen S; Romppanen T; Pulkki K; Pyörälä M; Koivula I; Jantunen E; Juutilainen A
Eur J Haematol; 2020 Dec; 105(6):731-740. PubMed ID: 32740997
[TBL] [Abstract][Full Text] [Related]
11. Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper.
Cooksley T; Font C; Scotte F; Escalante C; Johnson L; Anderson R; Rapoport B
Support Care Cancer; 2021 Feb; 29(2):1129-1138. PubMed ID: 33230644
[TBL] [Abstract][Full Text] [Related]
12. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
Delebarre M; Dessein R; Lagrée M; Mazingue F; Sudour-Bonnange H; Martinot A; Dubos F
J Infect; 2019 Aug; 79(2):95-100. PubMed ID: 31228471
[TBL] [Abstract][Full Text] [Related]
13. Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis.
Kaya Z; Alıcı N; Kırkız S; Koçak Ü
Turk J Haematol; 2023 Aug; 40(3):183-186. PubMed ID: 37314294
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic C-reactive protein elevation in neutropenic children.
Sugiura S; Ito T; Koyama N; Sasaki N; Ikai H; Imanaka Y
Pediatr Int; 2017 Jan; 59(1):23-28. PubMed ID: 27362735
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study.
Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B
J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238
[TBL] [Abstract][Full Text] [Related]
17. Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Crawford R; Perkins NB; Hobbs DA; Hobbs ALV
Pharmacotherapy; 2022 Oct; 42(10):798-805. PubMed ID: 36106434
[TBL] [Abstract][Full Text] [Related]
18. Etiology and clinical course of febrile neutropenia in children with cancer.
Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral magnesium supplementation in reducing febrile neutropenia episodes in children with solid tumors treated with cisplatin-based chemotherapy: randomized clinical trial.
Castelán-Martínez OD; Palomo-Colli MA; Barrios-López VE; Silva-Jivaja KM; Juárez-Villegas LE; Castañeda-Hernández G; Sánchez-Rodríguez MA
Cancer Chemother Pharmacol; 2020 Nov; 86(5):673-679. PubMed ID: 33030582
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin Clearance, CD64, and HLA-DR as Predictors of Outcome in Febrile Neutropenic Children With Lymphoreticular Malignancies.
Gomber S; Banerjee A; Dewan P; Das S; Ansari MA; Rai G; Singh P
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e416-e422. PubMed ID: 32590420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
